Recombinant Canine CCL19 Protein
|Product Overview :
|Recombinant Canine CCL19 Protein (77aa) was expressed in yeast.
- Gene Information
- Related Products
|Molecular Mass :
|Protein length :
|AA sequence :
|GANDAEDCCL SVTQRPIPGN IVRAFHYLLI KDGCRLPAVV FTTLKGRQLC APPDQPWVDR IIRRLQKNSA KNKGHSS (77)
|>95% as visualized by SDS-PAGE analysis.
|This endotoxin-free recombinant protein can be used in cell culture, ELISA Standard, and as a Western Blot Control.
|Store at -20 centigrade.
|Gene Name :
|CCL19 C-C motif chemokine ligand 19 [ Canis lupus familiaris (dog) ]
|Official Symbol :
|Gene ID :
|mRNA Refseq :
|Protein Refseq :
|UniProt ID :
|◆ Recombinant Protein
|Recombinant Human CCL19 Protein, Biotinylated
|Active Recombinant Mouse Ccl19 Protein
|Recombinant Mouse CCL19 Protein, His (Fc)-Avi-tagged
|Active Recombinant Mouse Ccl19 Protein (83 aa)
|Recombinant Mouse CCL19 Protein
|Recombinant Human CCL19 293 Cell Lysate
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Q&As (6)Ask a question
There are still some limitations in the current research on CCL19, such as the lack of in-depth research on its specific mechanism of action and function, and the incomplete understanding of its relationship with diseases. In addition, since CCL19 is a multifunctional protein, regulating it may also have some side effects.
It has a complex relationship with other chemokines or proteins. For example, it binds to the CCR7 receptor, which directs the migration of immune cells. In addition, CCL19 interacts with other chemokines and cytokines to jointly regulate immune responses.
Therapeutic strategies for CCL19 include inhibition of its expression, modulation of its activity, or use of gene therapy. For example, some studies have shown that the use of small molecule inhibitors or antibodies against CCL19 can inhibit its activity and thus treat some CCL19-related diseases. In addition, related diseases can also be treated by regulating the expression level of CCL19.
In order to better understand the role of CCL19 in disease, further in-depth study of its specific mechanism of action and function is needed. In addition, it is also necessary to study the changes in its expression level and activity in different diseases, as well as its relationship with the occurrence and development of diseases. At the same time, it is also necessary to explore the clinical application prospects and effects of the therapeutic strategies that regulate them. This will contribute to the development of more effective treatments to improve outcomes and quality of life for patients with CCL19-related diseases.
CCL19 is mainly involved in the recruitment and activation of immune cells. It is able to exert immune defense by binding to receptors on the cell surface to direct immune cells to migrate to the site of inflammation or infection. In addition, CCL19 is also able to regulate the activation and differentiation of immune cells, affecting the type and intensity of immune responses.
Recent studies have found that CCL19 is also involved in the production and maintenance of lymphatic vessels. These processes have an important impact on the migration of immune cells and the regulation of immune responses, and also provide new ideas for the treatment of some diseases related to CCL19.
Customer Reviews (3)Write a review
The quality of the production is stable, and the batch-to-batch and intra-batch repeatability is good.
CCL19 has a complete range of specifications and is suitable for experiments of different scales.
The preparation is simple and we can do it ourselves.
Ask a Question for All CCL19 Products
Required fields are marked with *
My Review for All CCL19 Products
Required fields are marked with *